AstraZeneca Threatens UK Exit Over Drug Pricing
Update: 2025-10-06
Description
AstraZeneca threatens to pull UK investment! Is the NHS drug pricing system killing innovation? Chairman Shaun Grady warns Britain's outdated policies are pushing pharma giants away, jeopardizing a £650M investment and leaving patients without cutting-edge treatments. With a £200M Cambridge upgrade already paused and government talks stalled, can the UK revamp its approach before it's too late?
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
